RhumbLine Advisers’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-46,782
| Closed | -$233K | – | 3182 |
|
|
2021
Q1 | $233K | Sell |
46,782
-1,870
| -4% | -$9.31K | ﹤0.01% | 2789 |
|
|
2020
Q4 | $210K | Buy |
48,652
+3,640
| +8% | +$15.7K | ﹤0.01% | 2821 |
|
|
2020
Q3 | $193K | Sell |
45,012
-5,350
| -11% | -$22.9K | ﹤0.01% | 2702 |
|
|
2020
Q2 | $226K | Buy |
50,362
+2,350
| +5% | +$10.5K | ﹤0.01% | 2717 |
|
|
2020
Q1 | $192K | Hold |
48,012
| – | – | ﹤0.01% | 2599 |
|
|
2019
Q4 | $407K | Buy |
48,012
+329
| +0.7% | +$2.79K | ﹤0.01% | 2460 |
|
|
2019
Q3 | $327K | Sell |
47,683
-375
| -0.8% | -$2.57K | ﹤0.01% | 2535 |
|
|
2019
Q2 | $400K | Buy |
48,058
+4,740
| +11% | +$39.5K | ﹤0.01% | 2456 |
|
|
2019
Q1 | $397K | Buy |
43,318
+3,477
| +9% | +$31.9K | ﹤0.01% | 2424 |
|
|
2018
Q4 | $436K | Buy |
39,841
+15,128
| +61% | +$166K | ﹤0.01% | 2360 |
|
|
2018
Q3 | $345K | Buy |
24,713
+322
| +1% | +$4.5K | ﹤0.01% | 2450 |
|
|
2018
Q2 | $260K | Buy |
24,391
+1,626
| +7% | +$17.3K | ﹤0.01% | 2603 |
|
|
2018
Q1 | $197K | Buy |
22,765
+2,275
| +11% | +$19.7K | ﹤0.01% | 2609 |
|
|
2017
Q4 | $194K | Sell |
20,490
-3,639
| -15% | -$34.5K | ﹤0.01% | 2643 |
|
|
2017
Q3 | $189K | Buy |
24,129
+1,280
| +6% | +$10K | ﹤0.01% | 2764 |
|
|
2017
Q2 | $197K | Buy |
+22,849
| New | +$197K | ﹤0.01% | 2766 |
|